WPA
GILD icon

Wealth Preservation Advisors’s Gilead Sciences GILD Stock Holding History

Wealth Preservation Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1K Sell
137
-79
-37% -$11.1K 0.02% 325
2025
Q4 		$26.5K Buy
216
+81
+60% +$9.84K 0.01% 241
2025
Q3 		$15K Hold
135
– – 0.01% 271
2025
Q2 		$15K Hold
135
– – 0.01% 270
2025
Q1 		$15.1K Buy
+135
New +$13.9K 0.01% 284

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wealth Preservation Advisors's GILD Position: Q1 2026 in Review

Wealth Preservation Advisors reduced its Gilead Sciences (GILD) stake by 37% in Q1 2026, selling an estimated $11.1K and leaving 137 shares worth $19.1K. The position accounts for 0.02% of the portfolio, ranked #325.

Wealth Preservation Advisors first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $26.5K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wealth Preservation Advisors held 137 shares of Gilead Sciences worth $19.1K as of Q1 2026.
  • Wealth Preservation Advisors sold 79 Gilead Sciences shares in Q1 2026, an estimated $11.1K.
  • Gilead Sciences made up 0.02% of Wealth Preservation Advisors's portfolio in Q1 2026, its #325 holding.
  • Wealth Preservation Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Wealth Preservation Advisors's Gilead Sciences position peaked at $26.5K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.